Abiopharma

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

Phillips 66 to Speak at J.P. Morgan 2026 Energy, Power, Renewables & Mining Conference

Caseys Announces Fourth Quarter and Fiscal Year Results

Announcing Forward’s Letter of Intent to Brera Holdings PLC (SLMT)

Circle to Speak at VivaTech 2026

Snap-on Acquires Diesel Laptops

U.S. FDA Accepts Takedas Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohns Disease

Ming Shing Group Holdings Limited Announces Closing of the Acquisition of PMA Nano Carbon Tech Limited and Issuance of Unsecured Convertible Promissory Notes

Big Digital Energy, Inc. Terminates Existing Stockholder Rights Agreement

Mitsubishi HC Capital and Brookfield Partner to Launch Renewable Energy Company